All In MedTech

Device Trial Radar · NCT07847619

8 vs 12 Weeks: A Pavlik Harness Trial

Optimising Post-Centring Pavlik Time in Infant DDH: A Non-Inferiority RCT of 8 vs 12 Weeks

Last checked: Nov 19, 2026Latest source record: Sep 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Not yet recruitingPivotal-lookingRandomized with 110 participants. This is a heuristic, not a regulatory label.

Status

Not yet recruiting

Enrollment

110

Planned (sponsor's estimate)

Start

Jan 2027

Primary completion

Jan 2030

Study completion Mar 2030

Sponsor

Lead sponsor
The Hospital for Sick ChildrenAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Sep 29, 2026

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 0 months, up to 6 months
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Developmental dysplasia of the hip is the most common bone and joint condition in babies. It is usually treated with a harness that holds the hips in a safe position so they can develop normally. After the hip is confirmed to be in the correct position, babies are commonly kept in the harness for up to 12 weeks or more. While effective, wearing a harness for this length of time can be challenging for families. It can make everyday care such as feeding, bathing and dressing more difficult, and add stress during an important time for bonding. This trial compares two treatment options: 8 versus 12 weeks of harness wear. The 8-week option is being tested because research has shown that most hips appear normal on ultrasound by this point. The main measure of success is whether the hip looks normal on x-ray two years after treatment. Families will also be asked about their experience and treatment-related problems. If the shorter option is as effective as the longer option, many babies could spend less time in brace, reducing burden without compromising outcomes. Because this trial is embedded in routine care, results can be put into practice quickly and guide care for babies across Ontario and beyond.

Conditions

  • Developmental Dysplasia of Hip
  • DDH
  • Developmental Dysplasia of the Hip
  • Developmental Dysplasia of the Hip (DDH)
  • Hip Dysplasia, Developmental
  • Hip Dysplasia, Congenital, Nonsyndromic

Interventions

  • Pavlik HarnessDevice

    The intervention is the duration of Pavlik harness use after sonographic centring. The Pavlik harness itself is unchanged: a commercially available soft brace positioning the hips in flexion and abduction to maintain reduction. No modifications are introduced to fitting technique, wear schedule, caregiver education, skin checks, or monitoring. All care follows the existing SickKids protocol used in routine practice. The harness is worn full time (24 hours/day initially), with allowance for up to 1 hour/day removal for hygiene after 5 weeks of treatment.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Acetabular Index at 24 Months of AgeTime frame: At 24 months of age, with an allowable assessment window of ±3 months.

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • The Hospital for Sick Children

    Toronto, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.